Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TMA Precision Health provides AI-enabled precision medicine and diagnostic services for rare disease patients through whole genome sequencing, data aggregation, and expert interpretation. They collaborate with healthcare payers, pharma, and technology partners to generate actionable, genome-based treatment insights and rich real-world datasets for research and trial recruitment, accelerating diagnosis and enabling personalized treatment for rare genetic diseases. The company reports rapid turnaround for patients and measurable health system savings, but does not have traditional drug clinical results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TMA Precision Health.